ZTA Biotech
ZTA Biotech is the Intellectual Rights holder of the protocol and is represented by a Hungarian scientist. The formula was developed by an international team of researchers including a Canadian, an Israeli, and a Dutch scholar. The main research direction is achieved by an in-house developed, highly specialized software package for simulation and modeling of critical protein-protein interactions. The results based on the prediction of the algorithm are analyzed and translated into commercial products.All by ZTA Biotech
Filter by
AllArticlesAudioEbooksEventsInfographicsNewsProductsSurveysDocumentsVideosVirtual EventsWebinars
New detection method represents a great step forward in determining if patients have had COVID-19 and if they might still have immunity to the disease
| 2 min read
Page 1 of 1 - 1 Total Items
